Disclosure : this comparison is published by Obsidian, which makes one of the platforms discussed below. Our own product is described separately, in a box labelled as such, and is not ranked against the others. The descriptions of third-party platforms come from their public websites and materials as of 2026 ; contact each vendor for current features and pricing.
Life sciences and MedTech companies work under some of the strictest regulatory oversight in the world, from drug approvals and clinical trials to device classification and post-market surveillance. This page compares the regulatory intelligence platforms that pharma and MedTech regulatory affairs teams most often evaluate, in alphabetical order, without a ranking.
What makes life sciences regulatory intelligence specific?
- Product lifecycle dependency : a guidance change from the FDA or EMA can alter a submission strategy, a label or the clinical evidence required.
- Agency-specific practice : each health authority (FDA, EMA, MHRA, PMDA, TGA) has its own processes, publication formats and timelines.
- Competitive intelligence : beyond compliance, teams follow competitor approvals, clinical trial activity and warning letters.
- Speed of awareness : draft guidance often comes with a time-limited comment period.
- Many publication formats : guidance documents, Federal Register notices, safety communications, inspection reports, approval letters.
How do the main platforms compare? (alphabetical order)
Basil Systems (Basil Intel)
Basil Systems offers AI and machine-learning regulatory intelligence focused on MedTech, with data from the FDA, NIH, FOIA, TGA and Health Canada.
- Interactive 510(k) predicate navigation for medical devices
- Time-to-approval statistics and regulatory benchmarking
- Full-text search across 500,000+ clinical trial records
- Updated several times a day from primary sources
Typical fit : MedTech teams that need device-level competitive intelligence and product strategy. Pricing on request.
Cortellis Regulatory Intelligence (Clarivate)
Cortellis Regulatory Intelligence is Clarivate's platform for the global pharmaceutical regulatory landscape, with AI-assisted intelligence for compliance and strategic decisions.
- Large pharmaceutical regulatory database
- AI-assisted intelligence for compliance and planning
- Integration with the wider Clarivate life sciences data ecosystem
Typical fit : pharmaceutical regulatory affairs teams working on global development strategy. Enterprise pricing.
Lexim AI
Lexim AI offers RegIntel (regulatory intelligence) and Quantum eQMS, aggregating documents from 80+ health agencies including the FDA, EU bodies and the TGA.
- 100,000+ regulatory documents
- 50+ AI assistants for workflow automation
- Regulatory intelligence combined with a quality management system
Typical fit : teams that want regulatory intelligence and QMS in one platform. Pricing on request.
SyneticX (Leaf Intelligence)
SyneticX provides AI-driven regulatory research combining 10+ sources including the FDA, EMA, ClinicalTrials.gov and DailyMed.
- Automated Complete Response Letter (CRL) analysis
- Label change detection across marketed products
- Competitor tracking and regulatory pathway analysis
Typical fit : teams focused on regulatory research and competitive analysis. Pricing on request.
Thomson Reuters Regulatory Intelligence
Thomson Reuters offers editorial regulatory intelligence covering life sciences developments alongside financial regulation.
- Expert editorial analysis
- Historical regulatory archive
Typical fit : enterprises that value editorial commentary within a broader regulatory offering. Content follows an editorial production cycle ; premium enterprise pricing.
Our product : Obsidian (publisher of this page)
Obsidian monitors 6,700+ official sources, including health authorities such as the FDA, EMA, MHRA, Swissmedic, Health Canada and the TGA, with a Life Sciences and MedTech industry view. Every update links to the official publication it comes from.
- Monitoring with per-user alerts by agency, jurisdiction and topic
- An MCP server and an enterprise API to use the same verified data in AI assistants and internal tools
- Access after a short demo request, plans described on the pricing page
Limits to weigh : a monitoring and alerting tool, without competitive intelligence features such as predicate device analysis, clinical trial tracking or approval pathway benchmarking ; a younger product with a smaller analyst team than the established vendors above.
Comparison table (alphabetical, public information as of 2026)
| Platform | Primary function | Update speed | Device intelligence | Pharma intelligence | Pricing |
|---|---|---|---|---|---|
| Basil Systems | Device intelligence | Several times a day | Deep (510(k), PMA) | Limited | On request |
| Cortellis | Regulatory intelligence | Database updates | Limited | Extensive | Enterprise |
| Lexim AI | RegIntel + QMS | Database updates | Included | Included | On request |
| SyneticX | Regulatory research | AI-driven updates | Yes | Yes | On request |
| Thomson Reuters | Editorial intelligence | Editorial cycle | Editorial coverage | Editorial coverage | Premium enterprise |
| Obsidian (publisher of this page) | Regulatory monitoring | Continuous detection | Monitoring coverage | Monitoring coverage | Plans on the pricing page |
Monitoring or competitive intelligence?
- Regulatory monitoring tools track when health authorities publish guidance, rules, safety communications and approval decisions.
- Competitive and strategic intelligence tools analyse regulatory data for product-level insight : predicate devices, approval pathways, label comparison, competitor tracking.
Many regulatory affairs teams use one of each : monitoring so no relevant publication is missed, competitive intelligence for development and market-entry decisions.
How should a life sciences team choose?
- Agency coverage : check every health authority of your markets (FDA, EMA, MHRA and the national agencies).
- Publication types : guidance, Federal Register notices, safety communications, inspection reports.
- Speed of detection : it matters most for draft guidance with a comment period.
- Integration : RIMS, QMS or internal dashboards.
Run a trial or a demo with two or three platforms on your own products and markets before deciding.


